CME Group Inc. (NASDAQ:CME) Shares Purchased by Crestwood Advisors Group LLC

Crestwood Advisors Group LLC boosted its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 6.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,231 shares of the financial services provider's stock after acquiring an additional 7,139 shares during the period. Crestwood Advisors Group LLC's holdings in CME Group were worth $32,427,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Wayfinding Financial LLC bought a new stake in CME Group during the first quarter worth $25,000. Cornerstone Planning Group LLC grew its stake in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 55 shares during the period. New Age Alpha Advisors LLC grew its stake in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the period. Golden State Wealth Management LLC grew its stake in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 98 shares during the period. Finally, Alpine Bank Wealth Management bought a new position in shares of CME Group during the 1st quarter worth $32,000. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CME Group

In related news, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total transaction of $141,210.00. Following the transaction, the director directly owned 3,668 shares in the company, valued at $1,035,916.56. The trade was a 12.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Charles P. Carey sold 500 shares of the business's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the transaction, the director owned 4,900 shares in the company, valued at approximately $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,400 shares of company stock worth $3,680,610 over the last quarter. Insiders own 0.30% of the company's stock.

CME Group Price Performance

Shares of NASDAQ CME traded down $0.36 during mid-day trading on Tuesday, reaching $274.64. The company's stock had a trading volume of 2,682,922 shares, compared to its average volume of 2,185,184. The firm has a market capitalization of $98.97 billion, a PE ratio of 27.63, a P/E/G ratio of 4.81 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a fifty day moving average of $275.89 and a two-hundred day moving average of $261.04. CME Group Inc. has a 52 week low of $193.25 and a 52 week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the company earned $2.50 earnings per share. The firm's revenue was up 10.4% on a year-over-year basis. As a group, sell-side analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.82%. CME Group's payout ratio is 50.30%.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent analyst reports. Barclays raised their price target on CME Group from $283.00 to $299.00 and gave the company an "equal weight" rating in a report on Thursday, July 10th. UBS Group raised their price target on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a report on Friday, April 25th. Citigroup raised their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Piper Sandler raised their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Finally, Oppenheimer raised their price objective on CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, CME Group presently has an average rating of "Hold" and a consensus target price of $261.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.